John, unless you know something I don't, there will be a release of the August "Applications for New Human Medicines under Evaluation," as there has been every August. Lack of a formal August CHMP meeting doesn't change that. This updated spreadsheet will tell us whether Blarcamesine is still in clock stop (through extension) or whether the LoQ response was submitted and the review has resumed.
Market Data 
Markets 
AI
